Trial · NCT00042991
Adverse events861
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 861
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Stratum IA at Dose 100 mg/m^2 | 2 | 6 | |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Stratum IA at Dose 250 mg/m^2 | 22 | 43 | |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Stratum IA at Dose 375 mg/m^2 | 2 | 7 | |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Stratum IB at Dose 100 mg/m^2 | 0 | 2 | |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Stratum IB at Dose 250 mg/m^2 | 1 | 3 | |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Stratum IB at Dose 375 mg/m^2 | 1 | 5 | |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Stratum II at Dose 100 mg/m^2 | 1 | 3 | |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Stratum IA at Dose 100 mg/m^2 | 2 | 6 | |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Stratum IA at Dose 250 mg/m^2 | 13 | 43 | |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Stratum IA at Dose 375 mg/m^2 | 1 | 7 | |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Stratum IB at Dose 100 mg/m^2 | 0 | 2 | |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Stratum IB at Dose 250 mg/m^2 | 1 | 3 | |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Stratum IB at Dose 375 mg/m^2 | 1 | 5 | |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Stratum II at Dose 100 mg/m^2 | 1 | 3 | |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Stratum IA at Dose 100 mg/m^2 | 1 | 6 | |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Stratum IA at Dose 250 mg/m^2 | 15 | 43 | |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Stratum IA at Dose 375 mg/m^2 | 2 | 7 | |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Stratum IB at Dose 100 mg/m^2 | 1 | 2 | |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Stratum IB at Dose 250 mg/m^2 | 1 | 3 | |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Stratum IB at Dose 375 mg/m^2 | 3 | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00042991/events